Cheng, J., Ding, X., Xu, S., Zhu, B., & Jia, Q. (2020). Gene expression profiling identified TP53(Mut)PIK3CA(Wild) as a potential biomarker for patients with triple-negative breast cancer treated with immune checkpoint inhibitors. Oncol Lett.

Cheng, Jia'Nan, Xiaofang Ding, Shouxia Xu, Bo Zhu, and Qingzhu Jia. "Gene Expression Profiling Identified TP53(Mut)PIK3CA(Wild) As a Potential Biomarker for Patients With Triple-negative Breast Cancer Treated With Immune Checkpoint Inhibitors." Oncol Lett 2020.

Cheng, Jia'Nan, et al. "Gene Expression Profiling Identified TP53(Mut)PIK3CA(Wild) As a Potential Biomarker for Patients With Triple-negative Breast Cancer Treated With Immune Checkpoint Inhibitors." Oncol Lett 2020.